TNBC, clinically defined by the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression, forms about 20% of all breast cancer cases [2]. This evidence concerns the gene PGR and breast cancer.